Antiproliferative properties of human alveolar macrophages

被引:1
作者
Kessler, R
Dumont, S
Weitzenblum, E
Poindron, P
机构
[1] Univ Strasbourg, Dept Immunol Immunopharmacol & Pathol, Strasbourg, France
[2] Univ Strasbourg, Dept Pulmonol, Strasbourg, France
关键词
alveolar macrophages; lung cancer; cytotoxicity; gamma interferon; lipopolysaccharide;
D O I
10.1159/000029296
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: The aim of our study was to determine whether macrophages from lung cancer patients could acquire antitumoral properties in an in vitro model. Methods: We isolated macrophages from bronchoalveolar lavages performed in two groups of patients: patients with lung cancer and patients with lung infection. All patients were smokers. We used the inhibition of incorporation of H-3-thymidine by U937 tumoral cells as an in vitro cytostatic assay. Results: When stimulated by gamma interferon, alveolar macrophages either from lung cancer patients or from patients with lung infection induced cytostasis of proliferating U937 tumoral cells. This effect could be reproduced by using the supernatants of cultures of activated macrophages. When using optimal doses, gamma interferon showed an increased activity as compared with lipopolysaccharide. The combination of these two compounds was no more effective than gamma interferon alone in cancer patients. A macrophage/U937 tumoral cell ratio of 1/1 was sufficient to achieve a near-maximal cytostatic effect. Conclusions: Our results demonstrate that it is possible to activate, in vitro, alveolar macrophages from lung cancer patients by stimulation with gamma interferon. These macrophages acquire antiproliferative properties against a sensitive tumoral cell line.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 28 条
  • [1] AUDRAN R, 1994, CANCER IMMUNOL IMMUN, V39, P299, DOI 10.1007/s002620050129
  • [2] BRAUN DP, 1993, CANCER RES, V53, P3362
  • [3] MODULATION OF PULMONARY MACROPHAGE SUPEROXIDE RELEASE AND TUMORICIDAL ACTIVITY FOLLOWING ACTIVATION BY BIOLOGICAL RESPONSE MODIFIERS
    DRATH, DB
    [J]. IMMUNOPHARMACOLOGY, 1986, 12 (02): : 117 - 126
  • [4] DUMONT S, 1990, ANTICANCER RES, V10, P949
  • [5] AEROSOLIZED GAMMA-INTERFERON AND LIPOPOLYSACCHARIDE ENHANCES CYTOTOXICITY OF MURINE PULMONARY ALVEOLAR MACROPHAGES
    EISENBERG, BL
    TAYLOR, DD
    WEESE, JL
    [J]. JOURNAL OF IMMUNOTHERAPY, 1991, 10 (01) : 51 - 56
  • [6] PHASE-I TRIAL OF INTRAVENOUS-INFUSION OF EXVIVO-ACTIVATED AUTOLOGOUS BLOOD-DERIVED MACROPHAGES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER - TOXICITY AND IMMUNOMODULATORY EFFECTS
    FARADJI, A
    BOHBOT, A
    SCHMITTGOGUEL, M
    ROESLIN, N
    DUMONT, S
    WIESEL, ML
    LALLOT, C
    EBER, M
    BARTHOLEYNS, J
    POINDRON, P
    MORAND, G
    WITZ, JP
    OBERLING, F
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (05) : 319 - 326
  • [7] FEINMAN R, 1987, J IMMUNOL, V138, P635
  • [8] INHALED RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH LUNG-CANCER - PHARMACOKINETICS AND EFFECTS ON CHEMILUMINESCENCE RESPONSES OF ALVEOLAR MACROPHAGES AND PERIPHERAL-BLOOD NEUTROPHILS AND MONOCYTES
    HALME, M
    MAASILTA, P
    REPO, H
    RISTOLA, M
    TASKINEN, E
    MATTSON, K
    CANTELL, K
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (01): : 93 - 101
  • [9] HUMAN ALVEOLAR MACROPHAGES OF ANERGIC PATIENTS WITH LUNG-CANCER LACK THE RESPONSIVENESS TO RECOMBINANT INTERFERON-GAMMA
    KAWATSU, H
    HASEGAWA, Y
    TAKAGI, E
    SHIMOKATA, K
    [J]. CHEST, 1991, 100 (05) : 1277 - 1280
  • [10] MODULATION OF CELL-PROLIFERATION BY MACROPHAGES - POSSIBLE FUNCTION APART FROM CYTOTOXIC TUMOR REJECTION
    KELLER, R
    [J]. BRITISH JOURNAL OF CANCER, 1974, 30 (05) : 401 - 415